Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Lynch Syndrome Screening in Gynecological Cancers: Results of an International Survey with Recommendations for Uniform Reporting Terminology for Mismatch Repair Immunohistochemistry Results.

Ryan N, Wall J, Crosbie EJ, Arends M, Bosse T, Arif S, Faruqi A, Frayling I, Ganesan R, Hock YL, McMahon R, Manchanda R, McCluggage WG, Mukonoweshuro P, van Schalkwyk G, Side L, Smith JH, Tanchel B, Gareth Evans D, Gilks CB, Singh N; FRCPath.

Histopathology. 2019 Jul 16. doi: 10.1111/his.13925. [Epub ahead of print]

PMID:
31310679
2.

Does the vaginal microbiome drive cervical carcinogenesis?

Njoku K, Crosbie EJ.

BJOG. 2019 Jul 8. doi: 10.1111/1471-0528.15867. [Epub ahead of print]

PMID:
31286662
3.

Correction to: USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health.

Labonté R, Crosbie E, Gleeson D, McNamara C.

Global Health. 2019 Jul 1;15(1):44. doi: 10.1186/s12992-019-0482-x.

4.

Optimization of Window Study Endpoints in Endometrial Cancer.

Kitson SJ, Maskell Z, Sivalingam VN, Shaw J, Crosbie EJ.

Front Oncol. 2019 May 29;9:428. doi: 10.3389/fonc.2019.00428. eCollection 2019.

5.

Emerging threats of global preemption to nutrition labelling.

Crosbie E, Hatefi A, Schmidt L.

Health Policy Plan. 2019 Jun 7. pii: czz045. doi: 10.1093/heapol/czz045. [Epub ahead of print] No abstract available.

PMID:
31173105
6.

Epithelial ovarian cancer risk: A review of the current genetic landscape.

Flaum N, Crosbie EJ, Edmondson RJ, Smith MJ, Evans DG.

Clin Genet. 2019 May 16. doi: 10.1111/cge.13566. [Epub ahead of print] Review.

PMID:
31099061
7.

USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health.

Labonté R, Crosbie E, Gleeson D, McNamara C.

Global Health. 2019 May 14;15(1):35. doi: 10.1186/s12992-019-0476-8. Review. Erratum in: Global Health. 2019 Jul 1;15(1):44.

8.

The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis.

Ryan NAJ, Glaire MA, Blake D, Cabrera-Dandy M, Evans DG, Crosbie EJ.

Genet Med. 2019 May 14. doi: 10.1038/s41436-019-0536-8. [Epub ahead of print] Review.

PMID:
31086306
9.

Targeting Endometrial Cancer Stem Cell Activity with Metformin Is Inhibited by Patient-Derived Adipocyte-Secreted Factors.

Kitson SJ, Rosser M, Fischer DP, Marshall KM, Clarke RB, Crosbie EJ.

Cancers (Basel). 2019 May 11;11(5). pii: E653. doi: 10.3390/cancers11050653.

10.
11.

The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome.

Crosbie EJ, Ryan NAJ, Arends MJ, Bosse T, Burn J, Cornes JM, Crawford R, Eccles D, Frayling IM, Ghaem-Maghami S, Hampel H, Kauff ND, Kitchener HC, Kitson SJ, Manchanda R, McMahon RFT, Monahan KJ, Menon U, Møller P, Möslein G, Rosenthal A, Sasieni P, Seif MW, Singh N, Skarrott P, Snowsill TM, Steele R, Tischkowitz M; Manchester International Consensus Group, Evans DG.

Genet Med. 2019 Mar 28. doi: 10.1038/s41436-019-0489-y. [Epub ahead of print]

12.

A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Cancer Population: Cheap as NGS Chips?

Ryan NAJ, Davison NJ, Payne K, Cole A, Evans DG, Crosbie EJ.

Front Oncol. 2019 Feb 26;9:61. doi: 10.3389/fonc.2019.00061. eCollection 2019.

13.

Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.

Seppälä TT, Ahadova A, Dominguez-Valentin M, Macrae F, Evans DG, Therkildsen C, Sampson J, Scott R, Burn J, Möslein G, Bernstein I, Holinski-Feder E, Pylvänäinen K, Renkonen-Sinisalo L, Lepistö A, Lautrup CK, Lindblom A, Plazzer JP, Winship I, Tjandra D, Katz LH, Aretz S, Hüneburg R, Holzapfel S, Heinimann K, Valle AD, Neffa F, Gluck N, de Vos Tot Nederveen Cappel WH, Vasen H, Morak M, Steinke-Lange V, Engel C, Rahner N, Schmiegel W, Vangala D, Thomas H, Green K, Lalloo F, Crosbie EJ, Hill J, Capella G, Pineda M, Navarro M, Blanco I, Ten Broeke S, Nielsen M, Ljungmann K, Nakken S, Lindor N, Frayling I, Hovig E, Sunde L, Kloor M, Mecklin JP, Kalager M, Møller P.

Hered Cancer Clin Pract. 2019 Feb 28;17:8. doi: 10.1186/s13053-019-0106-8. eCollection 2019.

14.

Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases.

Morgan RD, Burghel GJ, Flaum N, Bulman M, Clamp AR, Hasan J, Mitchell CL, Schlecht H, Woodward ER, Lallo FI, Crosbie EJ, Edmondson RJ, Wallace AJ, Jayson GC, Evans DGR.

J Med Genet. 2019 May;56(5):301-307. doi: 10.1136/jmedgenet-2018-105792. Epub 2019 Jan 25.

PMID:
30683677
15.

Impact of surgical site infection (SSI) following gynaecological cancer surgery in the UK: a trainee-led multicentre audit and service evaluation.

O'Donnell RL, Angelopoulos G, Beirne JP, Biliatis I, Bolton H, Bradbury M, Craig E, Gajjar K, Mackintosh ML, MacNab W, Madhuri TK, McComiskey M, Myriokefalitaki E, Newton CL, Ratnavelu N, Taylor SE, Thangavelu A, Rhodes SA, Crosbie EJ, Edmondson RJ, Wan YL.

BMJ Open. 2019 Jan 24;9(1):e024853. doi: 10.1136/bmjopen-2018-024853.

16.

State Preemption to Prevent Local Taxation of Sugar-Sweetened Beverages.

Crosbie E, Schillinger D, Schmidt LA.

JAMA Intern Med. 2019 Jan 22. doi: 10.1001/jamainternmed.2018.7770. [Epub ahead of print] No abstract available.

PMID:
30667481
17.

Memoranda of understanding: a tobacco industry strategy to undermine illicit tobacco trade policies.

Crosbie E, Bialous S, Glantz SA.

Tob Control. 2019 Jan 18. pii: tobaccocontrol-2018-054668. doi: 10.1136/tobaccocontrol-2018-054668. [Epub ahead of print]

PMID:
30659106
18.

PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial.

Kitson SJ, Maskell Z, Sivalingam VN, Allen JL, Ali S, Burns S, Gilmour K, Latheef R, Slade RJ, Pemberton PW, Shaw J, Ryder WD, Kitchener HC, Crosbie EJ.

Clin Cancer Res. 2019 Apr 15;25(8):2424-2432. doi: 10.1158/1078-0432.CCR-18-3339. Epub 2018 Dec 18.

19.

High prevalence of metabolic syndrome in women newly diagnosed with endometrial cancer.

Kitson SJ, Lindsay J, Sivalingam VN, Rutter MK, Crosbie EJ.

Gynecol Oncol Rep. 2018 Aug 23;26:109-110. doi: 10.1016/j.gore.2018.08.006. eCollection 2018 Nov. No abstract available.

20.

Prevention Strategies in Endometrial Carcinoma.

MacKintosh ML, Crosbie EJ.

Curr Oncol Rep. 2018 Nov 13;20(12):101. doi: 10.1007/s11912-018-0747-1. Review.

21.

The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk.

MacKintosh ML, Derbyshire AE, McVey RJ, Bolton J, Nickkho-Amiry M, Higgins CL, Kamieniorz M, Pemberton PW, Kirmani BH, Ahmed B, Syed AA, Ammori BJ, Renehan AG, Kitchener HC, Crosbie EJ.

Int J Cancer. 2019 Feb 1;144(3):641-650. doi: 10.1002/ijc.31913. Epub 2018 Nov 20.

22.

Targeted lung cancer screening selects individuals at high risk of cardiovascular disease.

Balata H, Blandin Knight S, Barber P, Colligan D, Crosbie EJ, Duerden R, Elton P, Evison M, Greaves M, Howells J, Irion K, Karunaratne D, Kirwan M, Macnab A, Mellor S, Miller C, Newton T, Novasio J, Sawyer R, Sharman A, Slevin K, Smith E, Taylor B, Taylor S, Tonge J, Walsham A, Waplington S, Whittaker J, Booton R, Crosbie PAJ.

Lung Cancer. 2018 Oct;124:148-153. doi: 10.1016/j.lungcan.2018.08.006. Epub 2018 Aug 8.

PMID:
30268454
23.

The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol.

Ryan NAJ, Blake D, Cabrera-Dandy M, Glaire MA, Evans DG, Crosbie EJ.

Syst Rev. 2018 Aug 16;7(1):121. doi: 10.1186/s13643-018-0792-8.

24.

Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative.

Auguste A, Genestie C, De Bruyn M, Adam J, Le Formal A, Drusch F, Pautier P, Crosbie EJ, MacKay H, Kitchener HC, Powell M, Pollock PM, Mileshkin L, Edmondson RJ, Nout R, Nijman HW, Creutzberg CL, Bosse T, Leary A.

Mod Pathol. 2018 Dec;31(12):1851-1861. doi: 10.1038/s41379-018-0055-1. Epub 2018 Jun 28.

PMID:
29955143
25.

Pir2/Rnf144b is a potential endometrial cancer biomarker that promotes cell proliferation.

Zhou Q, Eldakhakhny S, Conforti F, Crosbie EJ, Melino G, Sayan BS.

Cell Death Dis. 2018 May 1;9(5):504. doi: 10.1038/s41419-018-0521-1.

26.

The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer.

Nagle CM, Crosbie EJ, Brand A, Obermair A, Oehler MK, Quinn M, Leung Y, Spurdle AB, Webb PM; Australian National Endometrial Cancer Study Group.

Gynecol Oncol. 2018 Jul;150(1):99-105. doi: 10.1016/j.ygyno.2018.04.006. Epub 2018 Apr 26.

PMID:
29706522
27.

Containing diffusion: the tobacco industry's multipronged trade strategy to block tobacco standardised packaging.

Crosbie E, Eckford R, Bialous S.

Tob Control. 2019 Mar;28(2):195-205. doi: 10.1136/tobaccocontrol-2017-054227. Epub 2018 Apr 21.

28.
29.

Findings Linking Mismatch Repair Mutation With Age at Endometrial and Ovarian Cancer Onset in Lynch Syndrome-Reply.

Crosbie EJ, Ryan NAJ, Evans DG.

JAMA Oncol. 2018 Jun 1;4(6):890-891. doi: 10.1001/jamaoncol.2018.0280. No abstract available.

PMID:
29621375
30.

Correction to: Recognizing Gynecological Cancer in Primary Care: Risk Factors, Red Flags, and Referrals.

Funston G, O'Flynn H, Ryan NAJ, Hamilton W, Crosbie EJ.

Adv Ther. 2018 Apr;35(4):590. doi: 10.1007/s12325-018-0692-2.

31.

Impact of Alternative Jet Fuels on Engine Exhaust Composition During the 2015 ECLIF Ground-Based Measurements Campaign.

Schripp T, Anderson B, Crosbie EC, Moore RH, Herrmann F, Oßwald P, Wahl C, Kapernaum M, Köhler M, Le Clercq P, Rauch B, Eichler P, Mikoviny T, Wisthaler A.

Environ Sci Technol. 2018 Apr 17;52(8):4969-4978. doi: 10.1021/acs.est.7b06244. Epub 2018 Apr 6.

PMID:
29601722
32.

Recognizing Gynecological Cancer in Primary Care: Risk Factors, Red Flags, and Referrals.

Funston G, O'Flynn H, Ryan NAJ, Hamilton W, Crosbie EJ.

Adv Ther. 2018 Apr;35(4):577-589. doi: 10.1007/s12325-018-0683-3. Epub 2018 Mar 7. Erratum in: Adv Ther. 2018 Apr 4;:.

33.

A multi-year data set on aerosol-cloud-precipitation-meteorology interactions for marine stratocumulus clouds.

Sorooshian A, MacDonald AB, Dadashazar H, Bates KH, Coggon MM, Craven JS, Crosbie E, Hersey SP, Hodas N, Lin JJ, Negrón Marty A, Maudlin LC, Metcalf AR, Murphy SM, Padró LT, Prabhakar G, Rissman TA, Shingler T, Varutbangkul V, Wang Z, Woods RK, Chuang PY, Nenes A, Jonsson HH, Flagan RC, Seinfeld JH.

Sci Data. 2018 Feb 27;5:180026. doi: 10.1038/sdata.2018.26.

34.

Advancing progressive health policy to reduce NCDs amidst international commercial opposition: Tobacco standardised packaging in Australia.

Crosbie E, Thomson G, Freeman B, Bialous S.

Glob Public Health. 2018 Dec;13(12):1753-1766. doi: 10.1080/17441692.2018.1443485. Epub 2018 Feb 27.

35.

Population-based testing of non-mucinous epithelial ovarian cancer in Scotland.

Evans DG, Edmondson R, Crosbie EJ.

BJOG. 2018 Oct;125(11):1459. doi: 10.1111/1471-0528.15174. Epub 2018 May 10. No abstract available.

PMID:
29460329
36.

Substantial Seasonal Contribution of Observed Biogenic Sulfate Particles to Cloud Condensation Nuclei.

Sanchez KJ, Chen CL, Russell LM, Betha R, Liu J, Price DJ, Massoli P, Ziemba LD, Crosbie EC, Moore RH, Müller M, Schiller SA, Wisthaler A, Lee AKY, Quinn PK, Bates TS, Porter J, Bell TG, Saltzman ES, Vaillancourt RD, Behrenfeld MJ.

Sci Rep. 2018 Feb 19;8(1):3235. doi: 10.1038/s41598-018-21590-9.

37.

Intraoperative interventions for preventing surgical site infection: an overview of Cochrane Reviews.

Liu Z, Dumville JC, Norman G, Westby MJ, Blazeby J, McFarlane E, Welton NJ, O'Connor L, Cawthorne J, George RP, Crosbie EJ, Rithalia AD, Cheng HY.

Cochrane Database Syst Rev. 2018 Feb 6;2:CD012653. doi: 10.1002/14651858.CD012653.pub2. Review.

38.

Aircraft Measurements of Total Mercury and Monomethyl Mercury in Summertime Marine Stratus Cloudwater from Coastal California, USA.

Weiss-Penzias P, Sorooshian A, Coale K, Heim W, Crosbie E, Dadashazar H, MacDonald AB, Wang Z, Jonsson H.

Environ Sci Technol. 2018 Mar 6;52(5):2527-2537. doi: 10.1021/acs.est.7b05395. Epub 2018 Feb 19.

PMID:
29401398
39.

Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.

Kitson S, Ryan N, MacKintosh ML, Edmondson R, Duffy JM, Crosbie EJ.

Cochrane Database Syst Rev. 2018 Feb 1;2:CD012513. doi: 10.1002/14651858.CD012513.pub2. Review.

40.

Human papillomavirus E7 induces p63 expression to modulate DNA damage response.

Eldakhakhny S, Zhou Q, Crosbie EJ, Sayan BS.

Cell Death Dis. 2018 Jan 26;9(2):127. doi: 10.1038/s41419-017-0149-6.

41.

Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer.

Latif A, Chadwick AL, Kitson SJ, Gregson HJ, Sivalingam VN, Bolton J, McVey RJ, Roberts SA, Marshall KM, Williams KJ, Stratford IJ, Crosbie EJ.

BMC Clin Pathol. 2017 Dec 28;17:27. doi: 10.1186/s12907-017-0067-7. eCollection 2017.

42.

Take-off engine particle emission indices for in-service aircraft at Los Angeles International Airport.

Moore RH, Shook MA, Ziemba LD, DiGangi JP, Winstead EL, Rauch B, Jurkat T, Thornhill KL, Crosbie EC, Robinson C, Shingler TJ, Anderson BE.

Sci Data. 2017 Dec 19;4:170198. doi: 10.1038/sdata.2017.198.

43.

BRCA and lynch syndrome-associated ovarian cancers behave differently.

Ryan NAJ, Bolton J, McVey RJ, Evans DG, Crosbie EJ.

Gynecol Oncol Rep. 2017 Nov 22;22:108-109. doi: 10.1016/j.gore.2017.11.007. eCollection 2017 Nov. No abstract available.

44.

The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: A prospective case control study.

Kitson SJ, Lindsay J, Sivalingam VN, Lunt M, Ryan NAJ, Edmondson RJ, Rutter MK, Crosbie EJ.

Gynecol Oncol. 2018 Jan;148(1):154-160. doi: 10.1016/j.ygyno.2017.11.019. Epub 2017 Nov 24.

45.

Corrigendum: Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome.

Atiomo W, Shafiee MN, Chapman C, Metzler VM, Abouzeid J, Latif A, Chadwick A, Kitson S, Sivalingam VN, Stratford IJ, Rutland CS, Persson JL, Ødum N, Fuentes-Utrilla P, Jeyapalan JN, Heery DM, Crosbie EJ, Mongan NP.

Clin Endocrinol (Oxf). 2017 Dec;87(6):886. doi: 10.1111/cen.13515. No abstract available.

PMID:
29160590
46.

Intracavity lavage and wound irrigation for prevention of surgical site infection.

Norman G, Atkinson RA, Smith TA, Rowlands C, Rithalia AD, Crosbie EJ, Dumville JC.

Cochrane Database Syst Rev. 2017 Oct 30;10:CD012234. doi: 10.1002/14651858.CD012234.pub2. Review.

47.

Tobacco control law implementation in a middle-income country: Transnational tobacco control network overcoming tobacco industry opposition in Colombia.

Uang R, Crosbie E, Glantz SA.

Glob Public Health. 2018 Aug;13(8):1050-1064. doi: 10.1080/17441692.2017.1357188. Epub 2017 Aug 17.

PMID:
28816610
48.

Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.

Ryan NAJ, Morris J, Green K, Lalloo F, Woodward ER, Hill J, Crosbie EJ, Evans DG.

JAMA Oncol. 2017 Dec 1;3(12):1702-1706. doi: 10.1001/jamaoncol.2017.0619.

49.

Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome.

Atiomo W, Shafiee MN, Chapman C, Metzler VM, Abouzeid J, Latif A, Chadwick A, Kitson S, Sivalingam VN, Stratford IJ, Rutland CS, Persson JL, Ødum N, Fuentes-Utrilla P, Jeyapalan JN, Heery DM, Crosbie EJ, Mongan NP.

Clin Endocrinol (Oxf). 2017 Nov;87(5):557-565. doi: 10.1111/cen.13436. Epub 2017 Aug 18. Erratum in: Clin Endocrinol (Oxf). 2017 Dec;87(6):886.

50.

Impact of Wildfire Emissions on Chloride and Bromide Depletion in Marine Aerosol Particles.

Braun RA, Dadashazar H, MacDonald AB, Aldhaif AM, Maudlin LC, Crosbie E, Aghdam MA, Hossein Mardi A, Sorooshian A.

Environ Sci Technol. 2017 Aug 15;51(16):9013-9021. doi: 10.1021/acs.est.7b02039. Epub 2017 Jul 27.

PMID:
28700243

Supplemental Content

Loading ...
Support Center